The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
Open accessAbstract
Background Molecular diagnostics are considered the most promising route to achievement of rapid, universal drug susceptibility testing for Mycobacterium tuberculosis complex (MTBC).We aimed to generate a WHO-endorsed catalogue of mutations to serve as a global standard for interpreting molecular information for drug resistance prediction. MethodsIn this systematic analysis, we used a candidate gene approach to identify mutations associated with resistance or consistent with susceptibility for 13 WHO-endorsed antituberculosis drugs.We collected existing worldwide MTBC whole-genome sequencing data and phenotypic data from academic groups and consortia, reference laboratories, public health organisations, and published literature.We categorised phenotypes as follows: methods and critical concentrations currently endorsed by WHO (category 1); critical concentrations previously endorsed by WHO for those methods (category 2); methods or critical concentrations not currently endorsed by WHO (category 3).For each mutation, we used a contingency table of binary phenotypes and presence or absence of the mutation to compute positive predictive value, and we used Fisher's exact tests to generate odds ratios and Benjamini-Hochberg corrected p values.Mutations were graded as associated with resistance if present in at least five isolates, if the odds ratio was more than 1 with a statistically significant corrected p value, and if the lower bound of the 95% CI on the positive predictive value for phenotypic resistance was greater than 25%.A series of expert rules were applied for final confidence grading of each mutation. FindingsWe analysed 41 137 MTBC isolates with phenotypic and whole-genome sequencing data from 45 countries.38 215 MTBC isolates passed quality control steps and were included in the final analysis.15 667 associations were computed for 13 211 unique mutations linked to one or more drugs.1149 (7•3%) of 15 667 mutations were classified as associated with phenotypic resistance and 107 (0•7%) were deemed consistent with susceptibility.For rifampicin, isoniazid, ethambutol, fluoroquinolones, and streptomycin, the mutations' pooled sensitivity was more than 80%.Specificity was over 95% for all drugs except ethionamide (91•4%), moxifloxacin (91•6%) and ethambutol (93•3%).Only two resistance mutations were identified for bedaquiline, delamanid, clofazimine, and linezolid as prevalence of phenotypic resistance was low for these drugs.Interpretation We present the first WHO-endorsed catalogue of molecular targets for MTBC drug susceptibility testing, which is intended to provide a global standard for resistance interpretation.The existence of this catalogue should encourage the implementation of molecular diagnostics by national tuberculosis programmes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walker, T. M., Kohl, T. A., Omar, S. V., Hedge, J., Del Ojo Elias, C., Bradley, P., Iqbal, Z., Feuerriegel, S., Niehaus, K. E., Wilson, D. J., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00062-6 · Cited by 638
Self-citationPrediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
The CRyPTIC Consortium and the 100, 0. G. P. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800474 · Cited by 500
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis
Coll, F., Phelan, J., Hill-Cawthorne, G. A., Nair, M. B., Mallard, K., Ali, S., Abdallah, A. M., Alghamdi, S., Alsomali, M., Ahmed, A. O., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0029-0 · Cited by 375
Self-citationAcquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
Bloemberg, G. V., Keller, P. M., Stucki, D., Trauner, A., Borrell, S., Latshang, T., Coscolla, M., Rothe, T., Hömke, R., Ritter, C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1505196 · Cited by 331
Self-citationMiotto, P., Tessema, B., Tagliani, E., Chindelevitch, L., Starks, A. M., Emerson, C., Hanna, D., Kim, P. S., Liwski, R., Zignol, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01354-2017 · Cited by 327
Self-citationKadura, S., King, N., Nakhoul, M., Zhu, H., Theron, G., Köser, C. U., & Farhat, M. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa136 · Cited by 208
Self-citationFarhat, M. R., Freschi, L., Calderon, R., Ioerger, T., Snyder, M., Meehan, C. J., de Jong, B., Rigouts, L., Sloutsky, A., Kaur, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10110-6 · Cited by 181
Self-citationFowler, P. W., Barilar, I., Battaglia, S., Borroni, E., Brandao, A. P., Brankin, A., Cabibbe, A. M., Carter, J. J., Cirillo, D. M., Claxton, P., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00239-2022 · Cited by 84
Self-citationMerker, M., Kohl, T. A., Barilar, I., Andres, S., Fowler, P. W., Chryssanthou, E., Ängeby, K., Juréen, P., Moradigaravand, D., Parkhill, J., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00726-5 · Cited by 83
Self-citationVargas, R., Freschi, L., Spitaleri, A., Tahseen, S., Barilar, I., Niemann, S., Miotto, P., Cirillo, D. M., Köser, C. U., & Farhat, M. R. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01164-21 · Cited by 70
Self-citation
Metadata
- Authors
- Walker, T. M., Miotto, P., Köser, C. U., Fowler, P. W., Knaggs, J., Iqbal, Z., Hunt, M., Chindelevitch, L., Farhat, M. R., Cirillo, D. M., Comas, I., Posey, J., Omar, S. V., Peto, T. E., Suresh, A., Uplekar, S., Laurent, S., Colman, R. E., Nathanson, C.-M., Zignol, M., Walker, A. S., Crook, D. W., Ismail, N., Rodwell, T. C., Walker, A. S., Steyn, A. J. C., Lalvani, A., Baulard, A., Christoffels, A., Mendoza-Ticona, A., Trovato, A., Skrahina, A., Lachapelle, A. S., Brankin, A., Piatek, A., Gibertoni Cruz, A., Koch, A., Cabibbe, A. M., Spitaleri, A., Brandao, A. P., Chaiprasert, A., Suresh, A., Barbova, A., Van Rie, A., Ghodousi, A., Bainomugisa, A., Mandal, A., Roohi, A., Javid, B., Zhu, B., Letcher, B., Rodrigues, C., Nimmo, C., NATHANSON, C.-M., Duncan, C., Coulter, C., Utpatel, C., Liu, C., Grazian, C., Kong, C., Köser, C. U., Wilson, D. J., Cirillo, D. M., Matias, D., Jorgensen, D., Zimenkov, D., Chetty, D., Moore, D. A., Clifton, D. A., Crook, D. W., van Soolingen, D., Liu, D., Kohlerschmidt, D., Barreira, D., Ngcamu, D., Santos Lazaro, E. D., Kelly, E., Borroni, E., Roycroft, E., Andre, E., Böttger, E. C., Robinson, E., Menardo, F., Mendes, F. F., Jamieson, F. B., Coll, F., Gao, G. F., Kasule, G. W., Rossolini, G. M., Rodger, G., Smith, E. G., Meintjes, G., Thwaites, G., Hoffmann, H., Albert, H., Cox, H., Laurenson, I. F., Comas, I., Arandjelovic, I., Barilar, I., Robledo, J., Millard, J., Johnston, J., Posey, J., Andrews, J. R., Knaggs, J., Gardy, J., Guthrie, J., Taylor, J., Werngren, J., Metcalfe, J., Coronel, J., Shea, J., Carter, J., Pinhata, J. M., Kus, J. V., Todt, K., Holt, K., Nilgiriwala, K. S., Ghisi, K. T., Malone, K. M., Faksri, K., Musser, K. A., Joseph, L., Rigouts, L., Chindelevitch, L., Jarrett, L., Grandjean, L., Ferrazoli, L., Rodrigues, M., Farhat, M., Schito, M., Fitzgibbon, M. M., Loembé, M. M., Wijkander, M., Ballif, M., Rabodoarivelo, M.-S., Mihalic, M., WILCOX, M., Hunt, M., ZIGNOL, M., Merker, M., Egger, M., O'Donnell, M., Caws, M., Wu, M.-H., Whitfield, M. G., Inouye, M., Mansjö, M., Dang Thi, M. H., Joloba, M., Kamal, S. M., Okozi, N., ISMAIL, N., Mistry, N., Hoang, N. N., Rakotosamimanana, N., Paton, N. I., Rancoita, P. M. V., Miotto, P., Lapierre, P., Hall, P. J., Tang, P., Claxton, P., Wintringer, P., Keller, P. M., Thai, P. V. K., Fowler, P. W., Supply, P., Srilohasin, P., Suriyaphol, P., Rathod, P., Kambli, P., Groenheit, R., Colman, R. E., Ong, R. T.-H., Warren, R. M., Wilkinson, R. J., Diel, R., Oliveira, R. S., Khot, R., Jou, R., Tahseen, S., Laurent, S., Gharbia, S., Kouchaki, S., Shah, S., Plesnik, S., Earle, S. G., Dunstan, S., Hoosdally, S. J., Mitarai, S., Gagneux, S., Omar, S. V., Yao, S.-Y., Grandjean Lapierre, S., Battaglia, S., Niemann, S., Pandey, S., Uplekar, S., Halse, T. A., Cohen, T., Cortes, T., Prammananan, T., Kohl, T. A., Thuong, N. T. T., Teo, T. Y., Peto, T. E. A., Rodwell, T. C., William, T., Walker, T. M., Rogers, T. R., Surve, U., Mathys, V., Furió, V., Cook, V., Vijay, S., Escuyer, V., Dreyer, V., Sintchenko, V., Saphonn, V., Solano, W., Lin, W.-H., van Gemert, W., He, W., Yang, Y., Zhao, Y., Qin, Y., Xiao, Y.-X., Hasan, Z., Iqbal, Z., & Puyen, Z. M.
- Venue
- The Lancet Microbe
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 3
- Issue
- 4
- Pages
- e265-e273
- ISSN
- 2666-5247 (ISSN-L)
- OpenAlex
- W3210823154
- Cited by
- 277
- References
- 17
- FWCI
- 28.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis. https://app.cochat.ai/papers/10.1016/s2666-5247(21)00301-3
- The paper
- Walker, T. M., Miotto, P., Köser, C. U., Fowler, P. W., Knaggs, J., Iqbal, Z., Hunt, M., Chindelevitch, L., Farhat, M. R., Cirillo, D. M., Comas, I., Posey, J., Omar, S. V., Peto, T. E., Suresh, A., Uplekar, S., Laurent, S., Colman, R. E., Nathanson, C.-M., . . . Puyen, Z. M. (2022). The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis. The Lancet Microbe. https://doi.org/10.1016/s2666-5247(21)00301-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.